These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 30647010)

  • 1. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
    Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou J; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts T; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ;
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):135-184. PubMed ID: 30647010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.
    Cooke GS; Flower B; Cunningham E; Marshall AD; Lazarus JV; Palayew A; Jia J; Aggarwal R; Al-Mahtab M; Tanaka Y; Jeong SH; Poovorawan K; Waked I; Hiebert L; Khue PM; Grebely J; Alcantara-Payawal D; Sanchez-Avila JF; Mbendi C; Muljono DH; Lesi O; Desalegn H; Hamid S; de Araujo A; Cheinquer H; Onyekwere CA; Malyuta R; Ivanchuk I; Thomas DL; Pimenov N; Chulanov V; Dirac MA; Han H; Ward JW
    Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):346-365. PubMed ID: 38367629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
    Duffell EF; Hedrich D; Mardh O; Mozalevskis A
    Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards elimination goals for viral hepatitis.
    Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
    Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
    Palayew A; Razavi H; Hutchinson SJ; Cooke GS; Lazarus JV
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):948-953. PubMed ID: 32730784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
    Al Awaidy ST; Ezzikouri S
    J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
    Qureshi H; Mahmood H; Sabry A; Hermez J
    J Infect Dis; 2023 Sep; 228(Suppl 3):S204-S210. PubMed ID: 37703344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global investment framework for the elimination of hepatitis B.
    Howell J; Pedrana A; Schroeder SE; Scott N; Aufegger L; Atun R; Baptista-Leite R; Hirnschall G; 't Hoen E; Hutchinson SJ; Lazarus JV; Olufunmilayo L; Peck R; Sharma M; Sohn AH; Thompson A; Thursz M; Wilson D; Hellard M
    J Hepatol; 2021 Mar; 74(3):535-549. PubMed ID: 32971137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
    Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020.
    Haering C; McMahon B; Harris A; Weis N; Lundberg Ederth J; Axelsson M; Olafsson S; Osiowy C; Tomas K; Bollerup S; Liitsola K; Archibald C; Blystad H; Bruce M; Nolen L
    Int J Circumpolar Health; 2021 Dec; 80(1):1986975. PubMed ID: 34668463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
    Schröeder SE; Pedrana A; Scott N; Wilson D; Kuschel C; Aufegger L; Atun R; Baptista-Leite R; Butsashvili M; El-Sayed M; Getahun A; Hamid S; Hammad R; 't Hoen E; Hutchinson SJ; Lazarus JV; Lesi O; Li W; Binti Mohamed R; Olafsson S; Peck R; Sohn AH; Sonderup M; Spearman CW; Swan T; Thursz M; Walker T; Hellard M; Howell J
    Liver Int; 2019 Oct; 39(10):1818-1836. PubMed ID: 31433902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
    Liu J; Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of the economic benefits of global hepatitis C elimination: an investment case.
    Scott N; Kuschel C; Pedrana A; Schroeder S; Howell J; Thompson A; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):940-947. PubMed ID: 32730785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research gaps in viral hepatitis.
    Boyd A; Duchesne L; Lacombe K
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Disparities in Hepatitis B Elimination-A Focus on Africa.
    Sonderup MW; Spearman CW
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024.
    Tohme RA; Shadaker S; Adamia E; Khonelidze I; Stvilia K; Getia V; Tsereteli M; Alkhazashvili M; Abutidze A; Butsashvili M; Gogia M; Glass N; Surguladze S; Schumacher IT; Gabunia T
    MMWR Morb Mortal Wkly Rep; 2024 Aug; 73(30):660-666. PubMed ID: 39088368
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.